Preliminary evidence suggests that these compounds may have some biological activity in slowing the growth of bladder cancer cells.

Uncontrolled cell growth is the hallmark of cancer.

We were simultaneously stopping the growth of new cancer cells and killing those already existing. This was most dramatic when we used the TPA/ATRA combination on the tumors.

[ERBITUX targets metastatic colorectal cancer cells expressing epidermal growth factor receptors (EGFR) on their surface. In Canada, an estimated 19,100 people are diagnosed with colorectal cancer every year. Half of these patients have metastatic disease, or cancer that has spread to other organs, at the time of diagnosis. EGFR is expressed in over 80 per cent of colorectal cancer tumours.] Colorectal cancer is the second leading cause of cancer deaths in Canada. New and potentially life-saving treatments are always welcome, ... We are pleased that ERBITUX is now approved for treatment of metastatic colorectal cancer in Canada.

Light, in terms of our experiments, stimulates breast-cancer growth activity, and obviously this is due to the ability of light to shut off melatonin production.

It's like they say about soldiers coming back from war. People all around you are dying. Really dying, Eric. You go in for a week's chemotherapy and you're in a ward with people who are really, actually dying, there and then and doing their best to come to terms with it. When the week's up, you go home and you see your family and your friends and everything's normal and familiar. It's too much. You think - one world can't possibly hold both these lives and you feel like you're going to go crazy when you realise the world is that big and it can fill with the most terrible things whenever it wants to.